Detalhe da pesquisa
1.
Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells.
Anticancer Drugs
; 29(10): 1011-1020, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096128
2.
Significance of AZD1152 as a potential treatment against Aurora B overexpression in acute promyelocytic leukemia.
Ann Hematol
; 95(7): 1031-42, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091351
3.
Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
Ann Hematol
; 92(9): 1207-20, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23645216
4.
Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-κB signaling pathway.
Life Sci
; 257: 118060, 2020 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645343
5.
Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
Cell Oncol (Dordr)
; 43(1): 81-93, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512195
6.
Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid).
Cancer Chemother Pharmacol
; 85(1): 47-59, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31786654
7.
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.
Sci Rep
; 7(1): 4204, 2017 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28646172